Strong Industry Presence Tidepool operates as a nonprofit in the rapidly growing diabetes management sector, with an estimated revenue between $50 million and $100 million, indicating substantial market influence and potential for collaborations with healthcare organizations and tech partners.

Innovation in Technology The company's development of the Tidepool Loop interoperable automated insulin pump system and its partnerships with major players like Medtronic and Embecta highlight opportunities to introduce complementary diabetes tech solutions and digital health tools.

Strategic Partnerships Recent collaborations with Ouraring Inc, HealthPartners, and the International Diabetes Center suggest a strong network for scaling digital health solutions and data integration platforms, creating avenues for joint ventures or licensing agreements.

Expanding Data Capabilities The addition of features like the Ambulatory Glucose Profile to the Tidepool Data Platform demonstrates the company’s focus on comprehensive data analytics and reporting, offering potential for sales of advanced health data management tools and analytics services.

Leadership and Growth With recent operational leadership appointments and ongoing development projects since 2019, Tidepool shows stability and growth momentum, making it a promising partner for sales of healthcare software, regulatory support, and related services in the diabetes technology space.